ArticleAntimicrobial agents and chemotherapy2008

Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs.

Hirotomo Nakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.